Join Codexis for a virtual KOL event featuring John Maraganore, PhD (Founder and Former Chief Executive Officer of Alnylam Pharmaceuticals) and David Butler, PhD (Chief Technology Officer at Hongene Biotech Corporation). These distinguished experts will join Codexis leadership to discuss the current RNA interference (RNAi) therapeutics manufacturing landscape and share their perspectives on the potential role of an enzymatic route of synthesis in commercial-scale production. During the event, Codexis management will also provide an overview of the ECO Synthesis™ platform and the associated commercial opportunity.

A live question and answer session will follow the formal presentations.